Skip to the line map
Before the Needle

How to Find Stem Cell Clinical Trials on ClinicalTrials.gov

  • Updated November 14, 2026
  • Stop 2 of 4 on the Trials, cost and insurance line

Search ClinicalTrials.gov by your condition and by the intervention, filter for studies that are recruiting and near you, then open each study record and read its eligibility criteria, intervention, sponsor, NCT number and last update date before contacting anyone. A listing on ClinicalTrials.gov is not FDA approval, not proof the treatment works, and not a guarantee you will qualify. For a given condition and location, there may be no relevant recruiting stem cell trial at the moment you search.

What ClinicalTrials.gov does and does not verify

ClinicalTrials.gov is a registry run by the U.S. National Library of Medicine. Study sponsors and investigators enter information about their studies: what is being tested, who can join, where and when. The site makes that information searchable and, for many studies, displays posted results.

What it does not do is approve, endorse or vouch for a study’s quality. The content is supplied by the sponsor. FDA’s patient information on regenerative medicine specifically warns that a listing on ClinicalTrials.gov does not mean a product is legally marketed, and that this is sometimes used to suggest compliance falsely.

Step 1: Search for your condition using precise and related terms

Open the search page and use the condition or disease field. Precision matters. “Knee osteoarthritis” targets the condition more narrowly than “knee pain” or “arthritis,” which also match unrelated studies. Try related terms as well: for example “osteoarthritis, knee” and “gonarthrosis,” or for a spine condition, “degenerative disc disease” and “low back pain, discogenic.”

Then use the intervention or treatment field for the product type. Try several: “mesenchymal stromal cells,” “mesenchymal stem cells,” “bone marrow aspirate concentrate,” “adipose-derived,” “stromal vascular fraction.” Because names vary, a single term will miss studies.

A reproducible example. Enter “knee osteoarthritis” as the condition and “mesenchymal” as the intervention, then apply the recruiting filter described below. Write down the date of your search and the exact terms, because results change as studies open, close and update. Do not assume this search will return an open study near you; the result depends on the day.

Step 2: Filter by recruiting status, location, and intervention

The most important filter is recruitment status. ClinicalTrials.gov uses nine overall recruitment statuses for studies:

Status What it means for you
Not yet recruiting The study has not started enrolling
Recruiting The study is currently enrolling participants
Enrolling by invitation Participants are selected by the investigators; you generally cannot apply
Active, not recruiting The study is ongoing but not enrolling new participants
Completed The study has ended normally
Suspended The study has stopped early, including recruitment, but may start again
Terminated The study stopped early and will not resume
Withdrawn The study stopped before enrolling its first participant
Unknown status The record's last status was recruiting, not yet recruiting, or active but not recruiting, and it has not been confirmed within the past two years; the study's actual status is unclear

Two of these are easy to misread. “Enrolling by invitation” is not open recruitment. “Unknown status” means the sponsor or investigator has not confirmed the record for two years, so the information may be out of date; it does not mean the study is open. A clinical research glossary that follows ClinicalTrials.gov definitions describes the two-year rule, and a trial-search glossary built on ClinicalTrials.gov data adds a second condition: the study has passed its completion date. You can check the current wording in ClinicalTrials.gov’s own glossary. Either way, the practical step is the same, because “Unknown status” never means a study is open: check the record’s “last verified” date and contact the study team before assuming anything about enrollment.

Expanded access is separate. Some records describe expanded access, a pathway for using an investigational product outside a clinical trial for a patient with a serious condition. Expanded access records use different status values: available, temporarily not available, no longer available, and approved for marketing. These describe whether that pathway is available, not whether a trial is recruiting.

Next, filter by location, using a country, state or city and distance. Then confirm the intervention in the record, since search filters match text and can return studies that mention a term only in passing.

Step 3: Read the NCT record before contacting anyone

Every registered study has an NCT number, a unique identifier in the form “NCT” followed by eight digits. Use it to refer to the study in any conversation. ClinicalTrials.gov offers a guide to reading a study record. In the record, look at:

  • Eligibility criteria: inclusion and exclusion criteria, including age, diagnosis, severity and prior treatments. A participant generally must meet all of the inclusion criteria and must not meet any of the exclusion criteria, so read both lists before contacting the team.
  • Arms and interventions: what each group receives, including whether there is a placebo or comparison group.
  • Phase: the stage of research. What each phase means is explained in what Phase 1, 2 and 3 mean in stem cell trials.
  • Sponsor and collaborators: who is running and funding the study.
  • Locations and contacts: which sites are enrolling and how to reach them.
  • Results: whether results have been posted.
  • Record dates: when the study was first posted and when it was last updated. An old “last update posted” date is a reason to confirm the status directly with the contact.

Step 4: Verify oversight, consent and practical participation details

When you contact a study team, ask:

  • Is the study conducted under an FDA Investigational New Drug application, and which institutional review board oversees it?
  • Will I receive the full informed consent document to read before deciding?
  • Which visits, tests and procedures are part of the study, and how often?
  • Which services, if any, might generate charges to me or my insurer?
  • What happens if I am injured during the study?

A legitimate study will explain the consent process and give you time to decide. Insurance questions about routine costs in clinical trials, including Medicare’s rules, are covered in whether health insurance covers stem cell therapy.

What to do if the search returns no relevant trials

That is a legitimate result, not a failed search. Try synonyms for the condition and intervention, widen the location, and check again later, since new studies are registered over time. Ask your treating clinician whether they know of studies at nearby academic centers. Be cautious of any clinic that offers to enroll you in a “study” that you cannot find on a registry, or that charges for an investigational product outside a registered study.

ClinicalTrials.gov does not list only government-run studies; it includes studies run by companies, universities and other organizations worldwide. And a study marked “completed” means it ended, not that the treatment worked. Check for posted results or a published paper to see what it found.

Every stop on the Trials, cost and insurance line

  1. What Do Phase 1, 2, and 3 Mean in Stem Cell Clinical Trials?
  2. How to Find Stem Cell Clinical Trials on ClinicalTrials.gov
  3. How Much Does Stem Cell Therapy Cost in the United States?
  4. Does Health Insurance Cover Stem Cell Therapy in the United States?

Reader comments

Leave a note on this stop

Your email address will not be published. Required fields are marked *